首页> 美国卫生研究院文献>PLoS Clinical Trials >Visualising the Cross-Level Relationships between Pathological and Physiological Processes and Gene Expression: Analyses of Haematological Diseases
【2h】

Visualising the Cross-Level Relationships between Pathological and Physiological Processes and Gene Expression: Analyses of Haematological Diseases

机译:可视化病理和生理过程与基因表达之间的跨层次关系:血液系统疾病分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The understanding of pathological processes is based on the comparison between physiological and pathological conditions, and transcriptomic analysis has been extensively applied to various diseases for this purpose. However, the way in which the transcriptomic data of pathological cells relate to the transcriptomes of normal cellular counterparts has not been fully explored, and may provide new and unbiased insights into the mechanisms of these diseases. To achieve this, it is necessary to develop a method to simultaneously analyse components across different levels, namely genes, normal cells, and diseases. Here we propose a multidimensional method that visualises the cross-level relationships between these components at three different levels based on transcriptomic data of physiological and pathological processes, by adapting Canonical Correspondence Analysis, which was developed in ecology and sociology, to microarray data (CCA on Microarray data, CCAM). Using CCAM, we have analysed transcriptomes of haematological disorders and those of normal haematopoietic cell differentiation. First, by analysing leukaemia data, CCAM successfully visualised known relationships between leukaemia subtypes and cellular differentiation, and their characteristic genes, which confirmed the relevance of CCAM. Next, by analysing transcriptomes of myelodysplastic syndromes (MDS), we have shown that CCAM was effective in both generating and testing hypotheses. CCAM showed that among MDS patients, high-risk patients had transcriptomes that were more similar to those of both haematopoietic stem cells (HSC) and megakaryocyte-erythroid progenitors (MEP) than low-risk patients, and provided a prognostic model. Collectively, CCAM reveals hidden relationships between pathological and physiological processes and gene expression, providing meaningful clinical insights into haematological diseases, and these could not be revealed by other univariate and multivariate methods. Furthermore, CCAM was effective in identifying candidate genes that are correlated with cellular phenotypes of interest. We expect that CCAM will benefit a wide range of medical fields.
机译:对病理过程的了解是基于生理和病理条件之间的比较,因此转录组学分析已广泛应用于各种疾病。但是,病理细胞的转录组数据与正常细胞对应的转录组相关的方式尚未得到充分探索,可能为这些疾病的机理提供新的和公正的见解。为此,有必要开发一种方法来同时分析不同水平的成分,即基因,正常细胞和疾病。在这里,我们提出了一种多维方法,该方法通过将在生态学和社会学领域发展起来的规范对应分析与微阵列数据相适应,基于生理学和病理学过程的转录组数据,可视化在三个不同级别上这些组件之间的跨层次关系。芯片数据(CCAM)。使用CCAM,我们分析了血液异常和正常造血细胞分化的转录组。首先,通过分析白血病数据,CCAM成功地可视化了白血病亚型与细胞分化及其特征基因之间的已知关系,从而证实了CCAM的相关性。接下来,通过分析骨髓增生异常综合症(MDS)的转录组,我们表明CCAM在产生和检验假设方面均有效。 CCAM显示,在MDS患者中,高风险患者的转录组与低风险患者的转录组与造血干细胞(HSC)和巨核红细胞祖细胞(MEP)的转录组更为相似,并提供了一种预后模型。 CCAM集体揭示了病理和生理过程与基因表达之间的隐藏关系,为血液学疾病提供了有意义的临床见解,而其他单变量和多变量方法则无法揭示这些隐患。此外,CCAM可有效地鉴定与感兴趣的细胞表型相关的候选基因。我们希望CCAM将使广泛的医学领域受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号